Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T19:45:55.554Z.
Calculation as of: 2026-10-06T19:45:55.554Z.
Quote observation: 2026-10-06T19:44:39.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 8f2565128bc52e6b8995a164e764e37a8d90e2a969ed0cbc93651ce94d5a839c
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Market Cap
$27.65M
Price/FCF Ratio
N/A
TTM Avg
87.13
3Y Avg
87.13
5Y Avg
45.44
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| aTyr Pharma, Inc. (ATYR) | $27.93M | N/A | N/A | N/A | N/A |
| Seres Therapeutics, Inc. (MCRB)vs › | $27.65M | N/A | 87.13 | 87.13 | 45.44 |
| OneMedNet Corporation (ONMD)vs › | $28.93M | N/A | 2.82 | 2.82 | 2.82 |
| Tevogen Bio Holdings Inc. (TVGN)vs › | $28.94M | N/A | N/A | N/A | N/A |
| BeyondSpring Inc. (BYSI)vs › | $29.20M | N/A | N/A | N/A | N/A |
| GridAI Technologies Corp. (GRDX)vs › | $29.24M | N/A | N/A | N/A | N/A |
| Context Therapeutics Inc. (CNTX)vs › | $29.37M | N/A | N/A | N/A | N/A |
| iTonic Holdings Ltd. (ITOC)vs › | $26.49M | N/A | N/A | N/A | N/A |
| Quantum Cyber N.V. (QUCY)vs › | $29.60M | N/A | N/A | N/A | N/A |
| Rockwell Medical, Inc. (RMTI)vs › | $29.92M | 19.43 | 16.64 | 18.03 | 18.03 |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
